Parallel Advisors
XBIO icon

Parallel Advisors’s Xenetic Biosciences XBIO Stock Holding History

Parallel Advisors’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2 Buy
+1
New +$3 ﹤0.01% 4029

Other funds holding XBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Darwin Wealth Management
Darwin Wealth Management Tampa, Florida $378M AUM 15.4% 1-Year Est. Return

Parallel Advisors's XBIO Position: Q3 2026 in Review

Parallel Advisors opened a new position in Xenetic Biosciences (XBIO) in Q3 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #4029 among its holdings.

6 funds tracked by Wall St. Rank hold XBIO as of Q3 2026.

  • Parallel Advisors held 1 share of Xenetic Biosciences worth $2 as of Q3 2026.
  • Xenetic Biosciences was a new Parallel Advisors position in Q3 2026.
  • Xenetic Biosciences made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #4029 holding.
  • 6 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.